Participants with Acute Respiratory Infections (ARI) in Outpatient Setting for Acute Respiratory Infection (ARGOS Trial)

"This trial is scheduled to span one day and aims to assess the prevalence of Influenza Virus. Additional goals include measuring relative risk of ARI-related hospitalization in participants that test positive for either Influenza or SARS-CoV-2 with/without Lower Respiratory Tract Disease (LRTD). LRTD refers to a new onset or worsening from chronic condition consisting of at least three symptoms, like coughing, breathlessness, phlegm production, etc. Furthermore, this study will also track percentage of those participating who presented complications during screening and were diagnosed with/without LRTD."

"Clinicaltrials.gov indicates that recruitment is ongoing for this trial, which was first made available to the public on December 20th 2021 and most recently updated on November 22nd 2022."

"Yes, according to clinicaltrials.gov this trial is actively accepting applications from eligible candidates. The original posting date was December 20th 2021 and the most recent update occurred on November 22nd 2022. This medical study needs 2960 patients at 42 sites in order to be completed successfully."

"This study has recruited patients from a wide variety of locations, such as Urgent Care Clinical Trials Fort Worth in Texas, Innovative Research of West Florida and Washington University School of Medicine based in Missouri. In total there are 42 sites participating."